Juvenile Xanthogranuloma — Trials

Juvenile Xanthogranuloma — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03155620	Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)	active not recruiting	Phase 2	1,377	National Cancer Institute (NCI)NIH	4	Jul 24, 2026	clinicaltrials
NCT04079179	Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders(NACHO-COBI)	recruiting	Phase 2	90	Carl AllenOTHER	1	Sep 18, 2025	clinicaltrials

Data updated 22 days agoSource updated Jul 24, 2026source: clinicaltrials